Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Harvard Researchers Look to the Fetus for Better Wound Healing
Harvard Researchers Look to the Fetus for Better Wound Healing
In-utero healing has provided a new pathway for better wound recovery.
Senators launch probe into why price of cancer drug increased 1400 percent
Senators launch probe into why price of cancer drug increased 1400 percent
Three U.
A Dangerous Antibiotic-Resistant Gene Has Spread The World. We Now Know Where It Started
A Dangerous Antibiotic-Resistant Gene Has Spread The World. We Now Know Where It Started
The mcr-1 gene, which helps bacteria resist colistin – one of the few remaining antibiotic drugs of last resort that still work – has now reached hospitals all across the world.
New drug attacks cancer-causing genes
New drug attacks cancer-causing genes
Two recent papers attack two cancer-related problems using the same drug.
Genentech offers HEMLIBRA update
Genentech offers HEMLIBRA update
Genentech.
New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®
New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®
RIDGEFIELD, Conn.
Bluebird, Celgene to share U.S. costs, profits on lead cancer CAR-T
Bluebird, Celgene to share U.S. costs, profits on lead cancer CAR-T
Bluebird bio has pulled the trigger on an option to co-develop and co-promote the anti-BCMA CAR-T treatment, bb2121, with Celgene in the U.
FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children
FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children
THOUSAND OAKS, Calif.
Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy study evaluating tafamidis for the treatment of transthyretin cardiomyopathy met its primary endpoint
Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy study evaluating tafamidis for the treatment of transthyretin cardiomyopathy met its primary endpoint
Pfizer Inc.
Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab
Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab
Zug, Switzerland – March 29, 2018 – Shire plc (LSE.
Israel aims for 100,000 people to volunteer for health database
Israel aims for 100,000 people to volunteer for health database
TEL AVIV (Reuters) - Israel plans to collect data over five years for its digital health project and hopes 100,000 people will volunteer to include their medical records in a database it estim...
Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial of PTG-100 for the Treatment of Ulcerative Colitis following Interim Analysis
Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial of PTG-100 for the Treatment of Ulcerative Colitis following Interim Analysis
NEWARK, Calif.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand